IBIO · iBio, Inc.
$1.41
+0.04 (+2.92%)
At close · Jul 21
Going-concern doubt
— cleared May 12, 2026
The latest filing states the doubt was alleviated.
“The history of significant losses, the negative cash flow from operations, and the dependence by the Company on its ability to obtain additional financing to fund its operations in the past raised substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed May 12, 2026
Market Cap
$67.81M
Shares
49.68M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.